CytomX Therapeutics, Inc. Amortization of Intangible Assets
CytomX Therapeutics, Inc. (CTMX) reported Amortization of Intangible Assets of $73.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- CytomX Therapeutics, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $36.00K, a 2.70% decline year-over-year.
- CytomX Therapeutics, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $37.00K, a 2.78% increase year-over-year.
- CytomX Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $37.00K, a 0.00% change year-over-year.
- CytomX Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $36.00K, a 0.00% change year-over-year.
- CytomX Therapeutics, Inc. amortization of intangible assets for fiscal 2025 was $146.00K, a 0.00% change from fiscal 2024.
- CytomX Therapeutics, Inc. amortization of intangible assets for fiscal 2024 was $146.00K, a 0.00% change from fiscal 2023.
- CytomX Therapeutics, Inc. amortization of intangible assets for fiscal 2023 was $146.00K, a 0.00% change from fiscal 2022.
- CytomX Therapeutics, Inc. amortization of intangible assets for fiscal 2022 was $146.00K, a 0.00% change from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $73.00K 10-Q · filed 2026-08-06 | $110.00K derived: sum of 3 quarters · filed 2026-08-06 | $146.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $37.00K 10-Q · filed 2026-05-07 | $74.00K derived: sum of 2 quarters · filed 2026-05-07 | $110.00K derived: sum of 3 quarters · filed 2026-05-07 | $147.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $73.00K derived: sum of 2 quarters · filed 2026-03-16 | $110.00K derived: sum of 3 quarters · filed 2026-08-06 | $146.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $73.00K derived: sum of 2 quarters · filed 2026-08-06 | $109.00K 10-Q · filed 2025-11-06 | $146.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $73.00K 10-Q · filed 2026-08-06 | $110.00K derived: sum of 3 quarters · filed 2026-08-06 | $146.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $36.00K 10-Q · filed 2026-05-07 | $73.00K derived: sum of 2 quarters · filed 2026-05-07 | $109.00K derived: sum of 3 quarters · filed 2026-05-07 | $146.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $73.00K derived: sum of 2 quarters · filed 2026-03-16 | $110.00K derived: sum of 3 quarters · filed 2026-03-16 | $146.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $73.00K derived: sum of 2 quarters · filed 2025-11-06 | $109.00K 10-Q · filed 2025-11-06 | $146.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $73.00K 10-Q · filed 2025-08-07 | $110.00K derived: sum of 3 quarters · filed 2025-08-07 | $146.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $36.00K 10-Q · filed 2025-05-12 | $73.00K derived: sum of 2 quarters · filed 2025-05-12 | $109.00K derived: sum of 3 quarters · filed 2025-05-12 | $146.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $73.00K derived: sum of 2 quarters · filed 2025-03-06 | $110.00K derived: sum of 3 quarters · filed 2025-03-06 | $146.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $73.00K derived: sum of 2 quarters · filed 2024-11-07 | $109.00K 10-Q · filed 2024-11-07 | $145.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $73.00K 10-Q · filed 2024-08-08 | $109.00K derived: sum of 3 quarters · filed 2024-08-08 | $146.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $36.00K 10-Q · filed 2024-05-08 | $72.00K derived: sum of 2 quarters · filed 2024-05-08 | $109.00K derived: sum of 3 quarters · filed 2024-05-08 | $145.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $73.00K derived: sum of 2 quarters · filed 2024-03-11 | $109.00K derived: sum of 3 quarters · filed 2024-03-11 | $146.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $73.00K derived: sum of 2 quarters · filed 2023-11-07 | $110.00K 10-Q · filed 2023-11-07 | $146.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $73.00K 10-Q · filed 2023-08-08 | $109.00K derived: sum of 3 quarters · filed 2023-08-08 | $146.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $37.00K 10-Q · filed 2023-05-09 | $73.00K derived: sum of 2 quarters · filed 2023-05-09 | $110.00K derived: sum of 3 quarters · filed 2023-05-09 | $147.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $36.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $73.00K derived: sum of 2 quarters · filed 2023-03-27 | $110.00K derived: sum of 3 quarters · filed 2023-03-27 | $146.00K 10-K/A · filed 2023-03-27 |
| 2021-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $74.00K derived: sum of 2 quarters · filed 2022-11-08 | $110.00K 10-Q · filed 2022-11-08 | $147.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $73.00K 10-Q · filed 2022-08-04 | $110.00K derived: sum of 3 quarters · filed 2023-03-27 | $147.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-03-31 | $36.00K 10-Q · filed 2022-05-05 | $73.00K derived: sum of 2 quarters · filed 2023-03-27 | $110.00K derived: sum of 3 quarters · filed 2023-03-27 | $146.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-12-31 | $37.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $74.00K derived: sum of 2 quarters · filed 2023-03-27 | $110.00K derived: sum of 3 quarters · filed 2023-03-27 | $146.00K 10-K/A · filed 2023-03-27 |
| 2020-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $73.00K derived: sum of 2 quarters · filed 2021-11-04 | $109.00K 10-Q · filed 2021-11-04 | $146.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $72.00K 10-Q · filed 2021-08-05 | $109.00K derived: sum of 3 quarters · filed 2023-03-27 | $145.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-03-31 | $36.00K 10-Q · filed 2021-05-06 | $73.00K derived: sum of 2 quarters · filed 2023-03-27 | $109.00K derived: sum of 3 quarters · filed 2023-03-27 | $146.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2019-12-31 | $37.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $73.00K derived: sum of 2 quarters · filed 2023-03-27 | $110.00K derived: sum of 3 quarters · filed 2023-03-27 | $146.00K 10-K/A · filed 2023-03-27 |
| 2019-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $73.00K derived: sum of 2 quarters · filed 2020-11-05 | $109.00K 10-Q · filed 2020-11-05 | $146.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $73.00K 10-Q · filed 2020-08-06 | $110.00K derived: sum of 3 quarters · filed 2021-02-24 | $146.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $36.00K 10-Q · filed 2020-05-07 | $73.00K derived: sum of 2 quarters · filed 2021-02-24 | $109.00K derived: sum of 3 quarters · filed 2021-02-24 | $146.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $73.00K derived: sum of 2 quarters · filed 2021-02-24 | $110.00K derived: sum of 3 quarters · filed 2021-02-24 | $146.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $73.00K derived: sum of 2 quarters · filed 2019-11-07 | $109.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $73.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $36.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $146.00K 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |